鼻腔内ドラッグデリバリーシステムのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Intranasal Drug Delivery System Market Insights, Forecast to 2028

• レポートコード：QY2207E09613 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の鼻腔内ドラッグデリバリーシステムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に鼻腔内ドラッグデリバリーシステムの世界市場のxxx％を占める「経鼻用ドロップ」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の鼻腔内ドラッグデリバリーシステムの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの鼻腔内ドラッグデリバリーシステム市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの鼻腔内ドラッグデリバリーシステム市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 鼻腔内ドラッグデリバリーシステムのグローバル主要メーカーには、Aptar Pharma、Nemera、Teleflex、Mystic Pharmaceuticals、Zeteo Medical、Johnson & Johnson、GlaxoSmithKline Plc、Aegis Therapeutics LLC、H&T Presspart Manufacturing Ltd.、AstraZeneca Plc、Becton、BD、Novartis AG、Vectura Group Plcなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 鼻腔内ドラッグデリバリーシステム市場は、種類と用途によって区分されます。世界の鼻腔内ドラッグデリバリーシステム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 経鼻用ドロップ、経鼻用スプレー、経鼻用ゲル、経鼻用懸濁液・乳剤、経鼻用粉末 【用途別セグメント】 病院、クリニック、在宅医療、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 鼻腔内ドラッグデリバリーシステム製品概要 - 種類別市場（経鼻用ドロップ、経鼻用スプレー、経鼻用ゲル、経鼻用懸濁液・乳剤、経鼻用粉末） - 用途別市場（病院、クリニック、在宅医療、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の鼻腔内ドラッグデリバリーシステム販売量予測2017-2028 - 世界の鼻腔内ドラッグデリバリーシステム売上予測2017-2028 - 鼻腔内ドラッグデリバリーシステムの地域別販売量 - 鼻腔内ドラッグデリバリーシステムの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別鼻腔内ドラッグデリバリーシステム販売量 - 主要メーカー別鼻腔内ドラッグデリバリーシステム売上 - 主要メーカー別鼻腔内ドラッグデリバリーシステム価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（経鼻用ドロップ、経鼻用スプレー、経鼻用ゲル、経鼻用懸濁液・乳剤、経鼻用粉末） - 鼻腔内ドラッグデリバリーシステムの種類別販売量 - 鼻腔内ドラッグデリバリーシステムの種類別売上 - 鼻腔内ドラッグデリバリーシステムの種類別価格 ・用途別市場規模（病院、クリニック、在宅医療、その他） - 鼻腔内ドラッグデリバリーシステムの用途別販売量 - 鼻腔内ドラッグデリバリーシステムの用途別売上 - 鼻腔内ドラッグデリバリーシステムの用途別価格 ・北米市場 - 北米の鼻腔内ドラッグデリバリーシステム市場規模（種類別、用途別） - 主要国別の鼻腔内ドラッグデリバリーシステム市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの鼻腔内ドラッグデリバリーシステム市場規模（種類別、用途別） - 主要国別の鼻腔内ドラッグデリバリーシステム市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の鼻腔内ドラッグデリバリーシステム市場規模（種類別、用途別） - 主要国別の鼻腔内ドラッグデリバリーシステム市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の鼻腔内ドラッグデリバリーシステム市場規模（種類別、用途別） - 主要国別の鼻腔内ドラッグデリバリーシステム市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの鼻腔内ドラッグデリバリーシステム市場規模（種類別、用途別） - 主要国別の鼻腔内ドラッグデリバリーシステム市場規模（トルコ、サウジアラビア） ・企業情報 Aptar Pharma、Nemera、Teleflex、Mystic Pharmaceuticals、Zeteo Medical、Johnson & Johnson、GlaxoSmithKline Plc、Aegis Therapeutics LLC、H&T Presspart Manufacturing Ltd.、AstraZeneca Plc、Becton、BD、Novartis AG、Vectura Group Plc ・産業チェーン及び販売チャネル分析 - 鼻腔内ドラッグデリバリーシステムの産業チェーン分析 - 鼻腔内ドラッグデリバリーシステムの原材料 - 鼻腔内ドラッグデリバリーシステムの生産プロセス - 鼻腔内ドラッグデリバリーシステムの販売及びマーケティング - 鼻腔内ドラッグデリバリーシステムの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 鼻腔内ドラッグデリバリーシステムの産業動向 - 鼻腔内ドラッグデリバリーシステムのマーケットドライバー - 鼻腔内ドラッグデリバリーシステムの課題 - 鼻腔内ドラッグデリバリーシステムの阻害要因 ・主な調査結果

Market Analysis and Insights: Global Intranasal Drug Delivery System Market
Due to the COVID-19 pandemic, the global Intranasal Drug Delivery System market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Nasal Drops accounting for % of the Intranasal Drug Delivery System global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Intranasal Drug Delivery System market size is valued at US$ million in 2021, while the US and Europe Intranasal Drug Delivery System are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Intranasal Drug Delivery System landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Intranasal Drug Delivery System include Aptar Pharma, Nemera, Teleflex, Mystic Pharmaceuticals, Zeteo Medical, Johnson & Johnson, GlaxoSmithKline Plc, Aegis Therapeutics LLC and H&T Presspart Manufacturing Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Intranasal Drug Delivery System Scope and Segment
Intranasal Drug Delivery System market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Intranasal Drug Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Nasal Drops
Nasal Sprays
Nasal Gels
Nasal Suspensions and Emulsion
Nasal Powders
Segment by Application
Hospital
Clinic
Home Care
Others
By Company
Aptar Pharma
Nemera
Teleflex
Mystic Pharmaceuticals
Zeteo Medical
Johnson & Johnson
GlaxoSmithKline Plc
Aegis Therapeutics LLC
H&T Presspart Manufacturing Ltd.
AstraZeneca Plc
Becton
BD
Novartis AG
Vectura Group Plc
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Intranasal Drug Delivery System Product Introduction
1.2 Market by Type
1.2.1 Global Intranasal Drug Delivery System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Nasal Drops
1.2.3 Nasal Sprays
1.2.4 Nasal Gels
1.2.5 Nasal Suspensions and Emulsion
1.2.6 Nasal Powders
1.3 Market by Application
1.3.1 Global Intranasal Drug Delivery System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Intranasal Drug Delivery System Sales Estimates and Forecasts 2017-2028
2.2 Global Intranasal Drug Delivery System Revenue Estimates and Forecasts 2017-2028
2.3 Global Intranasal Drug Delivery System Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Intranasal Drug Delivery System Sales by Region
2.4.1 Global Intranasal Drug Delivery System Sales by Region (2017-2022)
2.4.2 Global Sales Intranasal Drug Delivery System by Region (2023-2028)
2.5 Global Intranasal Drug Delivery System Revenue by Region
2.5.1 Global Intranasal Drug Delivery System Revenue by Region (2017-2022)
2.5.2 Global Intranasal Drug Delivery System Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Intranasal Drug Delivery System Sales by Manufacturers
3.1.1 Global Top Intranasal Drug Delivery System Manufacturers by Sales (2017-2022)
3.1.2 Global Intranasal Drug Delivery System Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intranasal Drug Delivery System in 2021
3.2 Global Intranasal Drug Delivery System Revenue by Manufacturers
3.2.1 Global Intranasal Drug Delivery System Revenue by Manufacturers (2017-2022)
3.2.2 Global Intranasal Drug Delivery System Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Intranasal Drug Delivery System Revenue in 2021
3.3 Global Intranasal Drug Delivery System Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Intranasal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Intranasal Drug Delivery System Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Intranasal Drug Delivery System Sales by Type
4.1.1 Global Intranasal Drug Delivery System Historical Sales by Type (2017-2022)
4.1.2 Global Intranasal Drug Delivery System Forecasted Sales by Type (2023-2028)
4.1.3 Global Intranasal Drug Delivery System Sales Market Share by Type (2017-2028)
4.2 Global Intranasal Drug Delivery System Revenue by Type
4.2.1 Global Intranasal Drug Delivery System Historical Revenue by Type (2017-2022)
4.2.2 Global Intranasal Drug Delivery System Forecasted Revenue by Type (2023-2028)
4.2.3 Global Intranasal Drug Delivery System Revenue Market Share by Type (2017-2028)
4.3 Global Intranasal Drug Delivery System Price by Type
4.3.1 Global Intranasal Drug Delivery System Price by Type (2017-2022)
4.3.2 Global Intranasal Drug Delivery System Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Intranasal Drug Delivery System Sales by Application
5.1.1 Global Intranasal Drug Delivery System Historical Sales by Application (2017-2022)
5.1.2 Global Intranasal Drug Delivery System Forecasted Sales by Application (2023-2028)
5.1.3 Global Intranasal Drug Delivery System Sales Market Share by Application (2017-2028)
5.2 Global Intranasal Drug Delivery System Revenue by Application
5.2.1 Global Intranasal Drug Delivery System Historical Revenue by Application (2017-2022)
5.2.2 Global Intranasal Drug Delivery System Forecasted Revenue by Application (2023-2028)
5.2.3 Global Intranasal Drug Delivery System Revenue Market Share by Application (2017-2028)
5.3 Global Intranasal Drug Delivery System Price by Application
5.3.1 Global Intranasal Drug Delivery System Price by Application (2017-2022)
5.3.2 Global Intranasal Drug Delivery System Price Forecast by Application (2023-2028)
6 North America
6.1 North America Intranasal Drug Delivery System Market Size by Type
6.1.1 North America Intranasal Drug Delivery System Sales by Type (2017-2028)
6.1.2 North America Intranasal Drug Delivery System Revenue by Type (2017-2028)
6.2 North America Intranasal Drug Delivery System Market Size by Application
6.2.1 North America Intranasal Drug Delivery System Sales by Application (2017-2028)
6.2.2 North America Intranasal Drug Delivery System Revenue by Application (2017-2028)
6.3 North America Intranasal Drug Delivery System Market Size by Country
6.3.1 North America Intranasal Drug Delivery System Sales by Country (2017-2028)
6.3.2 North America Intranasal Drug Delivery System Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Intranasal Drug Delivery System Market Size by Type
7.1.1 Europe Intranasal Drug Delivery System Sales by Type (2017-2028)
7.1.2 Europe Intranasal Drug Delivery System Revenue by Type (2017-2028)
7.2 Europe Intranasal Drug Delivery System Market Size by Application
7.2.1 Europe Intranasal Drug Delivery System Sales by Application (2017-2028)
7.2.2 Europe Intranasal Drug Delivery System Revenue by Application (2017-2028)
7.3 Europe Intranasal Drug Delivery System Market Size by Country
7.3.1 Europe Intranasal Drug Delivery System Sales by Country (2017-2028)
7.3.2 Europe Intranasal Drug Delivery System Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Intranasal Drug Delivery System Market Size by Type
8.1.1 Asia Pacific Intranasal Drug Delivery System Sales by Type (2017-2028)
8.1.2 Asia Pacific Intranasal Drug Delivery System Revenue by Type (2017-2028)
8.2 Asia Pacific Intranasal Drug Delivery System Market Size by Application
8.2.1 Asia Pacific Intranasal Drug Delivery System Sales by Application (2017-2028)
8.2.2 Asia Pacific Intranasal Drug Delivery System Revenue by Application (2017-2028)
8.3 Asia Pacific Intranasal Drug Delivery System Market Size by Region
8.3.1 Asia Pacific Intranasal Drug Delivery System Sales by Region (2017-2028)
8.3.2 Asia Pacific Intranasal Drug Delivery System Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Intranasal Drug Delivery System Market Size by Type
9.1.1 Latin America Intranasal Drug Delivery System Sales by Type (2017-2028)
9.1.2 Latin America Intranasal Drug Delivery System Revenue by Type (2017-2028)
9.2 Latin America Intranasal Drug Delivery System Market Size by Application
9.2.1 Latin America Intranasal Drug Delivery System Sales by Application (2017-2028)
9.2.2 Latin America Intranasal Drug Delivery System Revenue by Application (2017-2028)
9.3 Latin America Intranasal Drug Delivery System Market Size by Country
9.3.1 Latin America Intranasal Drug Delivery System Sales by Country (2017-2028)
9.3.2 Latin America Intranasal Drug Delivery System Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Intranasal Drug Delivery System Market Size by Type
10.1.1 Middle East and Africa Intranasal Drug Delivery System Sales by Type (2017-2028)
10.1.2 Middle East and Africa Intranasal Drug Delivery System Revenue by Type (2017-2028)
10.2 Middle East and Africa Intranasal Drug Delivery System Market Size by Application
10.2.1 Middle East and Africa Intranasal Drug Delivery System Sales by Application (2017-2028)
10.2.2 Middle East and Africa Intranasal Drug Delivery System Revenue by Application (2017-2028)
10.3 Middle East and Africa Intranasal Drug Delivery System Market Size by Country
10.3.1 Middle East and Africa Intranasal Drug Delivery System Sales by Country (2017-2028)
10.3.2 Middle East and Africa Intranasal Drug Delivery System Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Aptar Pharma
11.1.1 Aptar Pharma Corporation Information
11.1.2 Aptar Pharma Overview
11.1.3 Aptar Pharma Intranasal Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Aptar Pharma Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Aptar Pharma Recent Developments
11.2 Nemera
11.2.1 Nemera Corporation Information
11.2.2 Nemera Overview
11.2.3 Nemera Intranasal Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Nemera Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Nemera Recent Developments
11.3 Teleflex
11.3.1 Teleflex Corporation Information
11.3.2 Teleflex Overview
11.3.3 Teleflex Intranasal Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Teleflex Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teleflex Recent Developments
11.4 Mystic Pharmaceuticals
11.4.1 Mystic Pharmaceuticals Corporation Information
11.4.2 Mystic Pharmaceuticals Overview
11.4.3 Mystic Pharmaceuticals Intranasal Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Mystic Pharmaceuticals Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mystic Pharmaceuticals Recent Developments
11.5 Zeteo Medical
11.5.1 Zeteo Medical Corporation Information
11.5.2 Zeteo Medical Overview
11.5.3 Zeteo Medical Intranasal Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Zeteo Medical Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Zeteo Medical Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Overview
11.6.3 Johnson & Johnson Intranasal Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Johnson & Johnson Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Johnson & Johnson Recent Developments
11.7 GlaxoSmithKline Plc
11.7.1 GlaxoSmithKline Plc Corporation Information
11.7.2 GlaxoSmithKline Plc Overview
11.7.3 GlaxoSmithKline Plc Intranasal Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 GlaxoSmithKline Plc Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GlaxoSmithKline Plc Recent Developments
11.8 Aegis Therapeutics LLC
11.8.1 Aegis Therapeutics LLC Corporation Information
11.8.2 Aegis Therapeutics LLC Overview
11.8.3 Aegis Therapeutics LLC Intranasal Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Aegis Therapeutics LLC Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Aegis Therapeutics LLC Recent Developments
11.9 H&T Presspart Manufacturing Ltd.
11.9.1 H&T Presspart Manufacturing Ltd. Corporation Information
11.9.2 H&T Presspart Manufacturing Ltd. Overview
11.9.3 H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 H&T Presspart Manufacturing Ltd. Recent Developments
11.10 AstraZeneca Plc
11.10.1 AstraZeneca Plc Corporation Information
11.10.2 AstraZeneca Plc Overview
11.10.3 AstraZeneca Plc Intranasal Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 AstraZeneca Plc Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 AstraZeneca Plc Recent Developments
11.11 Becton
11.11.1 Becton Corporation Information
11.11.2 Becton Overview
11.11.3 Becton Intranasal Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Becton Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Becton Recent Developments
11.12 BD
11.12.1 BD Corporation Information
11.12.2 BD Overview
11.12.3 BD Intranasal Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 BD Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 BD Recent Developments
11.13 Novartis AG
11.13.1 Novartis AG Corporation Information
11.13.2 Novartis AG Overview
11.13.3 Novartis AG Intranasal Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Novartis AG Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Novartis AG Recent Developments
11.14 Vectura Group Plc
11.14.1 Vectura Group Plc Corporation Information
11.14.2 Vectura Group Plc Overview
11.14.3 Vectura Group Plc Intranasal Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Vectura Group Plc Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Vectura Group Plc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Intranasal Drug Delivery System Industry Chain Analysis
12.2 Intranasal Drug Delivery System Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Intranasal Drug Delivery System Production Mode & Process
12.4 Intranasal Drug Delivery System Sales and Marketing
12.4.1 Intranasal Drug Delivery System Sales Channels
12.4.2 Intranasal Drug Delivery System Distributors
12.5 Intranasal Drug Delivery System Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Intranasal Drug Delivery System Industry Trends
13.2 Intranasal Drug Delivery System Market Drivers
13.3 Intranasal Drug Delivery System Market Challenges
13.4 Intranasal Drug Delivery System Market Restraints
14 Key Findings in The Global Intranasal Drug Delivery System Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Intranasal Drug Delivery System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Nasal Drops
Table 3. Major Manufacturers of Nasal Sprays
Table 4. Major Manufacturers of Nasal Gels
Table 5. Major Manufacturers of Nasal Suspensions and Emulsion
Table 6. Major Manufacturers of Nasal Powders
Table 7. Global Intranasal Drug Delivery System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Intranasal Drug Delivery System Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Intranasal Drug Delivery System Sales by Region (2017-2022) & (K Units)
Table 10. Global Intranasal Drug Delivery System Sales Market Share by Region (2017-2022)
Table 11. Global Intranasal Drug Delivery System Sales by Region (2023-2028) & (K Units)
Table 12. Global Intranasal Drug Delivery System Sales Market Share by Region (2023-2028)
Table 13. Global Intranasal Drug Delivery System Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Intranasal Drug Delivery System Revenue Market Share by Region (2017-2022)
Table 15. Global Intranasal Drug Delivery System Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Intranasal Drug Delivery System Revenue Market Share by Region (2023-2028)
Table 17. Global Intranasal Drug Delivery System Sales by Manufacturers (2017-2022) & (K Units)
Table 18. Global Intranasal Drug Delivery System Sales Share by Manufacturers (2017-2022)
Table 19. Global Intranasal Drug Delivery System Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Intranasal Drug Delivery System Revenue Share by Manufacturers (2017-2022)
Table 21. Intranasal Drug Delivery System Price by Manufacturers (2017-2022) &(US$/Unit)
Table 22. Global Intranasal Drug Delivery System Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Intranasal Drug Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Drug Delivery System as of 2021)
Table 24. Intranasal Drug Delivery System Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Intranasal Drug Delivery System Product Offered
Table 26. Date of Manufacturers Enter into Intranasal Drug Delivery System Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Intranasal Drug Delivery System Sales by Type (2017-2022) & (K Units)
Table 29. Global Intranasal Drug Delivery System Sales by Type (2023-2028) & (K Units)
Table 30. Global Intranasal Drug Delivery System Sales Share by Type (2017-2022)
Table 31. Global Intranasal Drug Delivery System Sales Share by Type (2023-2028)
Table 32. Global Intranasal Drug Delivery System Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Intranasal Drug Delivery System Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Intranasal Drug Delivery System Revenue Share by Type (2017-2022)
Table 35. Global Intranasal Drug Delivery System Revenue Share by Type (2023-2028)
Table 36. Intranasal Drug Delivery System Price by Type (2017-2022) & (US$/Unit)
Table 37. Global Intranasal Drug Delivery System Price Forecast by Type (2023-2028) & (US$/Unit)
Table 38. Global Intranasal Drug Delivery System Sales by Application (2017-2022) & (K Units)
Table 39. Global Intranasal Drug Delivery System Sales by Application (2023-2028) & (K Units)
Table 40. Global Intranasal Drug Delivery System Sales Share by Application (2017-2022)
Table 41. Global Intranasal Drug Delivery System Sales Share by Application (2023-2028)
Table 42. Global Intranasal Drug Delivery System Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Intranasal Drug Delivery System Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Intranasal Drug Delivery System Revenue Share by Application (2017-2022)
Table 45. Global Intranasal Drug Delivery System Revenue Share by Application (2023-2028)
Table 46. Intranasal Drug Delivery System Price by Application (2017-2022) & (US$/Unit)
Table 47. Global Intranasal Drug Delivery System Price Forecast by Application (2023-2028) & (US$/Unit)
Table 48. North America Intranasal Drug Delivery System Sales by Type (2017-2022) & (K Units)
Table 49. North America Intranasal Drug Delivery System Sales by Type (2023-2028) & (K Units)
Table 50. North America Intranasal Drug Delivery System Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Intranasal Drug Delivery System Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Intranasal Drug Delivery System Sales by Application (2017-2022) & (K Units)
Table 53. North America Intranasal Drug Delivery System Sales by Application (2023-2028) & (K Units)
Table 54. North America Intranasal Drug Delivery System Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Intranasal Drug Delivery System Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Intranasal Drug Delivery System Sales by Country (2017-2022) & (K Units)
Table 57. North America Intranasal Drug Delivery System Sales by Country (2023-2028) & (K Units)
Table 58. North America Intranasal Drug Delivery System Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Intranasal Drug Delivery System Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Intranasal Drug Delivery System Sales by Type (2017-2022) & (K Units)
Table 61. Europe Intranasal Drug Delivery System Sales by Type (2023-2028) & (K Units)
Table 62. Europe Intranasal Drug Delivery System Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Intranasal Drug Delivery System Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Intranasal Drug Delivery System Sales by Application (2017-2022) & (K Units)
Table 65. Europe Intranasal Drug Delivery System Sales by Application (2023-2028) & (K Units)
Table 66. Europe Intranasal Drug Delivery System Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Intranasal Drug Delivery System Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Intranasal Drug Delivery System Sales by Country (2017-2022) & (K Units)
Table 69. Europe Intranasal Drug Delivery System Sales by Country (2023-2028) & (K Units)
Table 70. Europe Intranasal Drug Delivery System Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Intranasal Drug Delivery System Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Intranasal Drug Delivery System Sales by Type (2017-2022) & (K Units)
Table 73. Asia Pacific Intranasal Drug Delivery System Sales by Type (2023-2028) & (K Units)
Table 74. Asia Pacific Intranasal Drug Delivery System Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Intranasal Drug Delivery System Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Intranasal Drug Delivery System Sales by Application (2017-2022) & (K Units)
Table 77. Asia Pacific Intranasal Drug Delivery System Sales by Application (2023-2028) & (K Units)
Table 78. Asia Pacific Intranasal Drug Delivery System Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Intranasal Drug Delivery System Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Intranasal Drug Delivery System Sales by Region (2017-2022) & (K Units)
Table 81. Asia Pacific Intranasal Drug Delivery System Sales by Region (2023-2028) & (K Units)
Table 82. Asia Pacific Intranasal Drug Delivery System Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Intranasal Drug Delivery System Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Intranasal Drug Delivery System Sales by Type (2017-2022) & (K Units)
Table 85. Latin America Intranasal Drug Delivery System Sales by Type (2023-2028) & (K Units)
Table 86. Latin America Intranasal Drug Delivery System Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Intranasal Drug Delivery System Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Intranasal Drug Delivery System Sales by Application (2017-2022) & (K Units)
Table 89. Latin America Intranasal Drug Delivery System Sales by Application (2023-2028) & (K Units)
Table 90. Latin America Intranasal Drug Delivery System Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Intranasal Drug Delivery System Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Intranasal Drug Delivery System Sales by Country (2017-2022) & (K Units)
Table 93. Latin America Intranasal Drug Delivery System Sales by Country (2023-2028) & (K Units)
Table 94. Latin America Intranasal Drug Delivery System Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Intranasal Drug Delivery System Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Intranasal Drug Delivery System Sales by Type (2017-2022) & (K Units)
Table 97. Middle East and Africa Intranasal Drug Delivery System Sales by Type (2023-2028) & (K Units)
Table 98. Middle East and Africa Intranasal Drug Delivery System Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Intranasal Drug Delivery System Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Intranasal Drug Delivery System Sales by Application (2017-2022) & (K Units)
Table 101. Middle East and Africa Intranasal Drug Delivery System Sales by Application (2023-2028) & (K Units)
Table 102. Middle East and Africa Intranasal Drug Delivery System Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Intranasal Drug Delivery System Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Intranasal Drug Delivery System Sales by Country (2017-2022) & (K Units)
Table 105. Middle East and Africa Intranasal Drug Delivery System Sales by Country (2023-2028) & (K Units)
Table 106. Middle East and Africa Intranasal Drug Delivery System Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Intranasal Drug Delivery System Revenue by Country (2023-2028) & (US$ Million)
Table 108. Aptar Pharma Corporation Information
Table 109. Aptar Pharma Description and Major Businesses
Table 110. Aptar Pharma Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 111. Aptar Pharma Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Aptar Pharma Recent Developments
Table 113. Nemera Corporation Information
Table 114. Nemera Description and Major Businesses
Table 115. Nemera Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 116. Nemera Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Nemera Recent Developments
Table 118. Teleflex Corporation Information
Table 119. Teleflex Description and Major Businesses
Table 120. Teleflex Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 121. Teleflex Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Teleflex Recent Developments
Table 123. Mystic Pharmaceuticals Corporation Information
Table 124. Mystic Pharmaceuticals Description and Major Businesses
Table 125. Mystic Pharmaceuticals Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 126. Mystic Pharmaceuticals Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Mystic Pharmaceuticals Recent Developments
Table 128. Zeteo Medical Corporation Information
Table 129. Zeteo Medical Description and Major Businesses
Table 130. Zeteo Medical Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 131. Zeteo Medical Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Zeteo Medical Recent Developments
Table 133. Johnson & Johnson Corporation Information
Table 134. Johnson & Johnson Description and Major Businesses
Table 135. Johnson & Johnson Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 136. Johnson & Johnson Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Johnson & Johnson Recent Developments
Table 138. GlaxoSmithKline Plc Corporation Information
Table 139. GlaxoSmithKline Plc Description and Major Businesses
Table 140. GlaxoSmithKline Plc Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 141. GlaxoSmithKline Plc Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. GlaxoSmithKline Plc Recent Developments
Table 143. Aegis Therapeutics LLC Corporation Information
Table 144. Aegis Therapeutics LLC Description and Major Businesses
Table 145. Aegis Therapeutics LLC Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 146. Aegis Therapeutics LLC Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Aegis Therapeutics LLC Recent Developments
Table 148. H&T Presspart Manufacturing Ltd. Corporation Information
Table 149. H&T Presspart Manufacturing Ltd. Description and Major Businesses
Table 150. H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 151. H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. H&T Presspart Manufacturing Ltd. Recent Developments
Table 153. AstraZeneca Plc Corporation Information
Table 154. AstraZeneca Plc Description and Major Businesses
Table 155. AstraZeneca Plc Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 156. AstraZeneca Plc Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. AstraZeneca Plc Recent Developments
Table 158. Becton Corporation Information
Table 159. Becton Description and Major Businesses
Table 160. Becton Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 161. Becton Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Becton Recent Developments
Table 163. BD Corporation Information
Table 164. BD Description and Major Businesses
Table 165. BD Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 166. BD Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. BD Recent Developments
Table 168. Novartis AG Corporation Information
Table 169. Novartis AG Description and Major Businesses
Table 170. Novartis AG Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 171. Novartis AG Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Novartis AG Recent Developments
Table 173. Vectura Group Plc Corporation Information
Table 174. Vectura Group Plc Description and Major Businesses
Table 175. Vectura Group Plc Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 176. Vectura Group Plc Intranasal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Vectura Group Plc Recent Developments
Table 178. Key Raw Materials Lists
Table 179. Raw Materials Key Suppliers Lists
Table 180. Intranasal Drug Delivery System Distributors List
Table 181. Intranasal Drug Delivery System Customers List
Table 182. Intranasal Drug Delivery System Market Trends
Table 183. Intranasal Drug Delivery System Market Drivers
Table 184. Intranasal Drug Delivery System Market Challenges
Table 185. Intranasal Drug Delivery System Market Restraints
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Intranasal Drug Delivery System Product Picture
Figure 3. Global Intranasal Drug Delivery System Market Share by Type in 2021 & 2028
Figure 3. Nasal Drops Product Picture
Figure 4. Nasal Sprays Product Picture
Figure 5. Nasal Gels Product Picture
Figure 6. Nasal Suspensions and Emulsion Product Picture
Figure 7. Nasal Powders Product Picture
Figure 8. Global Intranasal Drug Delivery System Market Share by Application in 2021 & 2028
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Home Care
Figure 12. Others
Figure 13. Intranasal Drug Delivery System Report Years Considered
Figure 14. Global Intranasal Drug Delivery System Sales 2017-2028 (K Units)
Figure 15. Global Intranasal Drug Delivery System Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Intranasal Drug Delivery System Revenue 2017-2028 (US$ Million)
Figure 17. Global Intranasal Drug Delivery System Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Intranasal Drug Delivery System Sales Market Share by Region (2017-2022)
Figure 19. Global Intranasal Drug Delivery System Sales Market Share by Region (2023-2028)
Figure 20. North America Intranasal Drug Delivery System Sales YoY (2017-2028) & (K Units)
Figure 21. North America Intranasal Drug Delivery System Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Intranasal Drug Delivery System Sales YoY (2017-2028) & (K Units)
Figure 23. Europe Intranasal Drug Delivery System Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Intranasal Drug Delivery System Sales YoY (2017-2028) & (K Units)
Figure 25. Asia-Pacific Intranasal Drug Delivery System Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Intranasal Drug Delivery System Sales YoY (2017-2028) & (K Units)
Figure 27. Latin America Intranasal Drug Delivery System Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Intranasal Drug Delivery System Sales YoY (2017-2028) & (K Units)
Figure 29. Middle East & Africa Intranasal Drug Delivery System Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Intranasal Drug Delivery System Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of Intranasal Drug Delivery System in the World: Market Share by Intranasal Drug Delivery System Revenue in 2021
Figure 32. Global Intranasal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global Intranasal Drug Delivery System Sales Market Share by Type (2017-2028)
Figure 34. Global Intranasal Drug Delivery System Revenue Market Share by Type (2017-2028)
Figure 35. Global Intranasal Drug Delivery System Sales Market Share by Application (2017-2028)
Figure 36. Global Intranasal Drug Delivery System Revenue Market Share by Application (2017-2028)
Figure 37. North America Intranasal Drug Delivery System Sales Market Share by Type (2017-2028)
Figure 38. North America Intranasal Drug Delivery System Revenue Market Share by Type (2017-2028)
Figure 39. North America Intranasal Drug Delivery System Sales Market Share by Application (2017-2028)
Figure 40. North America Intranasal Drug Delivery System Revenue Market Share by Application (2017-2028)
Figure 41. North America Intranasal Drug Delivery System Sales Share by Country (2017-2028)
Figure 42. North America Intranasal Drug Delivery System Revenue Share by Country (2017-2028)
Figure 43. United States Intranasal Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 44. Canada Intranasal Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 45. Europe Intranasal Drug Delivery System Sales Market Share by Type (2017-2028)
Figure 46. Europe Intranasal Drug Delivery System Revenue Market Share by Type (2017-2028)
Figure 47. Europe Intranasal Drug Delivery System Sales Market Share by Application (2017-2028)
Figure 48. Europe Intranasal Drug Delivery System Revenue Market Share by Application (2017-2028)
Figure 49. Europe Intranasal Drug Delivery System Sales Share by Country (2017-2028)
Figure 50. Europe Intranasal Drug Delivery System Revenue Share by Country (2017-2028)
Figure 51. Germany Intranasal Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 52. France Intranasal Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. Intranasal Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 54. Italy Intranasal Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 55. Russia Intranasal Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 56. Asia Pacific Intranasal Drug Delivery System Sales Market Share by Type (2017-2028)
Figure 57. Asia Pacific Intranasal Drug Delivery System Revenue Market Share by Type (2017-2028)
Figure 58. Asia Pacific Intranasal Drug Delivery System Sales Market Share by Application (2017-2028)
Figure 59. Asia Pacific Intranasal Drug Delivery System Revenue Market Share by Application (2017-2028)
Figure 60. Asia Pacific Intranasal Drug Delivery System Sales Share by Region (2017-2028)
Figure 61. Asia Pacific Intranasal Drug Delivery System Revenue Share by Region (2017-2028)
Figure 62. China Intranasal Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 63. Japan Intranasal Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 64. South Korea Intranasal Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 65. India Intranasal Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 66. Australia Intranasal Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 67. China Taiwan Intranasal Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia Intranasal Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand Intranasal Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia Intranasal Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Intranasal Drug Delivery System Sales Market Share by Type (2017-2028)
Figure 72. Latin America Intranasal Drug Delivery System Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Intranasal Drug Delivery System Sales Market Share by Application (2017-2028)
Figure 74. Latin America Intranasal Drug Delivery System Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Intranasal Drug Delivery System Sales Share by Country (2017-2028)
Figure 76. Latin America Intranasal Drug Delivery System Revenue Share by Country (2017-2028)
Figure 77. Mexico Intranasal Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Intranasal Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Intranasal Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Intranasal Drug Delivery System Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Intranasal Drug Delivery System Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Intranasal Drug Delivery System Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Intranasal Drug Delivery System Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Intranasal Drug Delivery System Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Intranasal Drug Delivery System Revenue Share by Country (2017-2028)
Figure 86. Turkey Intranasal Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Intranasal Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 88. UAE Intranasal Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 89. Intranasal Drug Delivery System Value Chain
Figure 90. Intranasal Drug Delivery System Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed

---